Dr J V Moore (Paterson Laboratories, Manchester), speaking on 'Experimental combinations of cytotoxic drugs and radiation', cited work performed with vincristine which -if given immediately before irradiation of intestinal cells -did not increase cell kill; however, when the cells were exposed to the drug seven hours before irradiation, the cell kill was markedly raised, probably as a result of cells being drawn into cycle. This temporal relationship varies with different drugs and tissues. He indicated that one possible mechanism for the enhanced radiation reaction seen when adriamycin or actinomycin D are added is a reduction in the cell's ability to accumulate sublethal damage. Work at the Royal Marsden Hospital, London, has shown that cyclophosphamide given two to three days before irradiation of normal animal tissues may exert a protective effect. In tumours, the use of chemotherapy prior to irradiation may result in a reduction in the number of hypoxic cells with improved oxygenation. This has been demonstrated in a mouse tumour system where the radiation dose required to produce local control was significantly reduced with prior chemotherapy.
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Secretory IgA and antigen handling in the gut 1 Immunology, like the Impressionist movement in painting, is the art of the unfinished. So with. immunoglobin A (IgA), whose physical properties have been known for many years but whose significance has only just begun to be appreciated. IgA is found in most mucosal secretions, particularly from the gut, as well as in colostrum, milk and saliva; in man this antibody comprises 13% of serum immunoglobulins. IgA is secreted by plasma cells which secrete, at the same time, a divalent junctional or J chain which binds the IgA associated peptide chains into dimers or higher polymers. Those monomers left unbound are not cleared by such organs as the liver and eventually constitute the majority of the IgA present in serum. Almost all dimeric IgA produced by mucosal plasma cells is transported across the mucosa, after binding to epithelial cell surface receptors, the surface secretory component (SC). The SC attaches to the immunoglobulin and gives IgA resistance to proteolytic digestion by gastrointestinal and intracellular enzymes. Some dimeric IgA produced in the gut wall enters the systemic circulation by the thoracic duct to be excreted by the liver. This explains the increase in serum dimeric IgA observed in animals with portacaval shunt (Vaerman et al. 1981 and actively transported from blood to bile by the hepatocytes (Orlans et al. 1978) . Up to half of an intravenously injected dose of 125iodine-Iabelled dimeric IgA is secreted into the bile within five hours. This process only occurs with dimers or higher polymers of IgA, which are able to bind to the secretory component displayed on the sinusoidal surfaces of the hepatocyte membranes (Reynolds et al. 1980) . The SC-IgA complex is then internalized in endocytic vesicles, transported across the hepatocyte cytoplasm and discharged into the biliary canaliculi (Birbeck et al. 1979) .
Direct immunization into Peyer's patches with bacterial antigens produced a high titre of specific IgA antibody in the bile with hardly detectable concentration of this class of antibody in the bloodstream . Fewer biliary antibodies are produced after direct splenic or subcutaneous immunization, the serum antibody raised in such circumstances being entirely confined to IgG or IgM class of antibody ). These antibodies are not transported to the bile since they are unable to combine with the SC component. Similarly, oral but not systemic immunization with poliovirus in man produces IgA in the gut secretions. This divergence of immune response can be reproduced experimentally with other antigens (Crabbe et al. 1969 , Bazine et at. 1970 . The relationship of IgA 'copro-antibodies' to protection and elimination of pathogens is still undecided. Well documented instances exist of patients who have high titres of antibody to enteric bacteria yet remain colonized 1') 1981 The Royal Society of Medicine by the bacteria concerned. What is certain is that a brisk IgA antibody response follows infection.
Dr H C Thomas and Dr J Dooley (Royal Free Hospital, London) suggested that hepatic excretion of IgA antibody is not so important in man as it appears from work on rodents. They demonstrated with radioiodine-labelled IgA, 1 1 3 1 for the monomer and 1 12 5 for the dimer, that the plasma half-life of injected dimeric IgA was 26 hours and monomeric IgA was 82 hours, with 0.5% of the injected dose of dimeric IgA being recovered from the bile in the first 24 hours. The appearance of dimer, but not the monomer, in saliva and urine of one patient, raises the possibility that all mucosal surfaces are involved in selective removal of dimeric IgA from the systemic circulation, not just the liver. The lack of hepatic participation in IgA secretion in man was reinforced by the finding that serum IgA did not rise in patients with extrahepatic portal vein obstruction and extensive portacaval shunting (Webb et al. 1980) . When Dr Thomas injected 1 1 2 5 radio labelled human IgA into rats, he found that 19-45% was cleared within eight hours, similar to the value found by Dr Hall when he injected homologous IgA into rats (see above).
Immunoregulation of IgA response by T lymphocytes was discussed by Dr A Ferguson, of the Western General Hospital, Edinburgh. T lymphocytes are found in the gut-associated lymphoid tissue both in Peyer's patches between the lymphoid follicles and in the subepithelial dome area and scattered in the mucosae. Studies in humans and mice, using a variety of antisera to T cell markers, have shown that 80-90% of intraepithelial lymphocytes are T cells, as are many of the lymphocytes found in the lamina propria. In rodents, traffic of intestinal lymphocytes has been examined by autoradiographic and immunofluorescent techniques. Blasts obtained from either mesenteric lymph nodes or thoracic duct lymph have been shown to home to the gut mucosa, where the T cells are found as intraepithelial lymphocytes and the B cells as plasma cells predominantly in the lamina propria. Cross traffic to other mucosal associated lymphoid tissues has been demonstrated. Recent experiments by Lamm (1981) involving sequential transfer of isotope labelled cells in mice, have confirmed directly that many mucosal IgA containing cells have precursors in the Peyer's patches. The physiology of 'homing' remains obscure.
Immunoregulation of 19A by T cells has been analysed in a series of clinical studies by Waldman's group (Waldman et al. 1976) . They have shown that IgA deficiency may relate to a lack in either the B cell line or T helper cell activity or may have arisen after an unduly high IgA specific suppressor T cell effect. The mechanism of immunoregulation of immunoglobulin-producing cells by the T cells present in Peyer's patches in mice could be relevant to the control of IgA secretion in the gastrointestinal tract in general. The problem was investigated in an in vitro system described by Elson, Heck & Strober (1979) , who used mouse lymphocytes incubated for seven days with lipopolysaccharide and then measured the resulting production of immunoglobulins found in the culture medium. The addition of Con A to the system, in a concentration which activated both T helper and T suppressor cells, produced suppression of IgG and IgM production in cultures of peripheral lymph nodes, spleen, mesenteric lymph node and Peyer's patches. Similar suppression of 19A production was obtained with all lymphocyte cultures except those derived from Peyer's patches. In these cultures, increased quantities of IgA were found. Confirmation that the regulatory T cell was responsible for enhanced production of IgA in the Peyer's patch cultures was obtained by adding Con A pulsed Peyer patch T cells to the Peyer's patch cell culture, which induced an even greater IgA synthesis while simultaneously suppressing IgA and IgM production.
Many of the functions of gut-associated lymphoid tissue correlate with activity of the immunoregulatory Tcell and the generation of the secretory antibody responses. An action which depends on the T suppressor lymphocyte is systemic tolerance after ingestion of antigen (Richman et al. 1978) , a phenomenon first reported in 1911 by Wells. He observed that guinea pigs fed ovalbumin lost their ability to develop anaphylaxis. The transfer of T helper cells from the gut, after deposition of T helper cell antigens there, explains how specific 19A antibodies are found in such extraintestinal sites as colostrum, lacrimal and salivary secretions (Mestecky et al. (978) . The suppression of mucosal cell-mediated responses in health by the transfer of T suppressor cells to the mucosa is yet a further instance of T cell mediated immune regulation, although cell-mediated reactions do develop in the mucosa in infectious and allergic disease.
As an antibody, IgA is relatively inert, although IgA has the ability to bind antigen to the variable region of the molecule and cause agglutination. The capacity to activate the alternative complement pathway (Colten & Bienenstock (974) and block immediate reactions (Platt-Mills et al. 1976) is only present to a limited extent. It is not surprising that IgA appears to be almost irrelevant to the pathogenesis of inflammatory bowel disease. Malabsorption and the development of unusual intestinal infections, on the other hand, are often accompanied by immunodeficiency syndromes with hypogammaglobulinaemia. However, treatment of infection restores absorption to normal, despite the continuing absence of immunoglobulins. Further evidence that immunoglobulins are not necessary for normal intestinal function is provided by the normal growth of germ-free immunodeficient children maintained in isolators, prior to attempts at immunologic reconstitution by transplantation of marrow or thymus.
Food allergic diseases are the outcome of breakdown in the normal state of tolerance to ingested antigens. Serum levels of IgA are lower in children with atopy and post-enteritis malabsorption than in controls. This may reflect abnormal immunoregulatory mechanisms other than pure IgA deficiency, as antibodies of IgA class to foodstuffs are found in the intestinal secretions of normal individuals as well as those with food allergic diseases such as coeliac disease. In spite of a raised IgA being found in an assortment of intestinal diseases, the role of immunoglobulin A remains mysterious.
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